|
|
RX COMPLIANCE REPORT
Rx Compliance Report is the only news source devoted exclusively to the government's crackdown on pharmaceutical sales and marketing practices. This 12-page bi-weekly newsletter uncovers emerging investigations and offers practical firsthand advice on implementing effective compliance programs. Rx Compliance Report focuses on the state and federal agencies leading these fraud and abuse investigations including the U.S. Dept. of Justice, the HHS OIG, state Attorneys General, state Medicaid Fraud Control Units, the Securities and Exchange Commission and the Federal Trade Commission. Readers include legal, regulatory, and compliance officers from nearly every major pharma company, and numerous biotech and medical device companies. Dozens of law firms, CME providers, and others also subscribe as well as DOJ, the OIG, and the FDA.
SUBSCRIPTION RATES:
Rx Compliance Report is available at the low annual rate of $597 (24 issues/year). Click here to subscribe.
Multi-issue discounts and licensing agreements are also available. Click here for more.
|
|
TOPICS:
|
Off-label promotion
Continuing medical education
Direct-to-Consumer (DTC) advertising
Drug pricing (Best price, AWP, Medicaid drug rebates)
False Claims Act strategic defenses
HIPAA/privacy |
|
Internet promotion
Sales force training
Sample accountability/PDMA
Sarbanes-Oxley
Monitoring and auditing
Compliance program development
|
|
EDITORIAL ADVISORY BOARD:
- Ted Acosta, Director of Pharma Compliance, Ernst & Young, New York NY, Former Senior Attorney, HHS OIG
- Ken Berkowitz, Bennett, Turner & Coleman, Pine Brook, NJ, President, HMC Council
- Regina Cavaliere, Vice President, Pharmaceutical Compliance, Alpharma Pharmaceuticals, Piscataway, NJ
- Marc Farley, Executive Director, Worldwide Compliance, Medical Devices & Diagnostics, Johnson & Johnson, New Brunswick, NJ, Former Assistant US Attorney for the District of NJ
- Laurence Freedman, Partner, Patton Boggs, Washington, DC, Former Assistant Director, Fraud Section, Commercial Litigation Branch, Civil Division, U.S. Department of Justice
- John Kamp, Executive Director, Healthcare Communications Council, New York, NY, Former Director, Office of Congressional & Public Affairs, Federal Communications Commission
- Daniel Kracov, Chair, Pharmaceutical & Medical Device Practice, Arnold & Porter, Washington, DC
- Marc Raspanti, Partner, Pietragallo Gordon Alfano Bosick & Raspant, Philadelphia PA
- William Sarraille, Partner, Sidley Austin Brown & Wood, Washington DC
- Paul Silver, Managing Director, Huron Consulting Group, Atlanta, GA
|
HOW TO ORDER:
To order, please choose one of the following options:
- One-year subscription -- $597 (24 issues) -- click here
- Multi-issue discounts and licensing agreements -- click here
Note: Rx Compliance Report is delivered in PDF-version only
|
|
|
